These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 11032503)

  • 1. [Complications suffered by dialysis patients. 3. Ca and P metabolism disorders of bone].
    Suzuki M
    Nihon Naika Gakkai Zasshi; 2000 Jul; 89(7):1358-65. PubMed ID: 11032503
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anomalies of phosphorus-calcium metabolism in renal insufficiency. Value of the physiopathological diagnosis and therapy].
    Hioco D; Dorfmann H; Chot ST; Bordier P; de Zèze S
    Rev Rhum Mal Osteoartic; 1972 Oct; 39(10):617-25. PubMed ID: 5083698
    [No Abstract]   [Full Text] [Related]  

  • 3. [SEN Guidelines. Recommendations of the Spanish Society of Nephrology for managing bone-mineral metabolic alterations in chronic renal disease patients].
    Torregrosa JV; Cannata Andia J; Bover J; Caravaca F; Lorenzo V; Martín de Francisco AL; Martín-Malo A; Martínez I; González Parra E; Fernández Giráldez E; Rodríguez Portillo M;
    Nefrologia; 2008; 28 Suppl 1():1-22. PubMed ID: 18338978
    [No Abstract]   [Full Text] [Related]  

  • 4. [Monostatic localization of bone dystrophy in patients under hemodialysis for chronic renal insufficiency].
    Noè C
    Arch Ital Urol Nefrol; 1971; 43(4):251-7. PubMed ID: 5130445
    [No Abstract]   [Full Text] [Related]  

  • 5. [Long-term dialysis and its problems: calcium and phosphorus metabolism disorders, aluminum balance, and esteodystrophy].
    Kurokawa K
    Nihon Rinsho; 1980 Jun; 38(6):2329-36. PubMed ID: 6997567
    [No Abstract]   [Full Text] [Related]  

  • 6. [Changes of calcium-phosphorus metabolism in patients with chronic renal failure on hemodialysis treatment].
    Pérez Ruilópez MA; Damiano Rivero A; Herrerías Echabe JM; Garrido Peralta M
    Rev Iber Endocrinol; 1976; 23(138):535-55. PubMed ID: 1013577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indications for parathyroidectomy in patients with chronic renal failure.
    Finch T; Jacobs JK
    Am Surg; 1974 Jan; 40(1):40-4. PubMed ID: 4808621
    [No Abstract]   [Full Text] [Related]  

  • 8. Calcium balance in dialysis is best managed by adjusting dialysate calcium guided by kinetic modeling of the interrelationship between calcium intake, dose of vitamin D analogues and the dialysate calcium concentration.
    Gotch F; Levin NW; Kotanko P
    Blood Purif; 2010; 29(2):163-76. PubMed ID: 20093823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone disease of chronic renal failure.
    Barona J; Randle White A; Bower JD
    J Miss State Med Assoc; 1979 Sep; 20(9):193-6. PubMed ID: 529273
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapeutic options for mineral metabolism disorders in dialysis patients: a case report].
    Cozzolino M; Pasho S; Missaglia E; Crovetto C; Fallabrino G; Brancaccio D
    G Ital Nefrol; 2008; 25(2):234-7. PubMed ID: 18350504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chronic renal insufficiency and calcium].
    Ogura Y; Sakai S; Kawaguchi Y; Yamamoto M; Kimura Y
    Nihon Rinsho; 1974 Mar; 32(3):463-70. PubMed ID: 4603390
    [No Abstract]   [Full Text] [Related]  

  • 12. [Review on internal medicine, 1973--nephrology. 6. Calcium metabolism in patients on regular dialysis treatment (author's transl)].
    Ogura Y
    Nihon Naika Gakkai Zasshi; 1974 Apr; 63(4):353-63. PubMed ID: 4605927
    [No Abstract]   [Full Text] [Related]  

  • 13. Osteodystrophy developing spontaneously in the course of chronic renal failure.
    Stanbury SW; Lumb GA; Mawer EB
    Arch Intern Med; 1969 Sep; 124(3):274-81. PubMed ID: 5806041
    [No Abstract]   [Full Text] [Related]  

  • 14. [The phosphocalcic and osseous metabolism disorders].
    Saggese G; Vierucci F
    Minerva Pediatr; 2009 Dec; 61(6):674-80. PubMed ID: 19935523
    [No Abstract]   [Full Text] [Related]  

  • 15. Mineral metabolism and renal bone disease: effects of CAPD versus hemodialysis.
    Coburn JW
    Kidney Int Suppl; 1993 Feb; 40():S92-100. PubMed ID: 8445845
    [No Abstract]   [Full Text] [Related]  

  • 16. Invited discussion.
    Bricker NS; Ogden DA; Schreiner GE; Walser M
    Arch Intern Med; 1969 Sep; 124(3):292-301. PubMed ID: 4896634
    [No Abstract]   [Full Text] [Related]  

  • 17. Calcium and phosphorus metabolism in patients who have chronic kidney disease.
    Goodman WG
    Med Clin North Am; 2005 May; 89(3):631-47. PubMed ID: 15755471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The use of xidifon for the correction of phosphorus-calcium metabolism in patients in the terminal stage of chronic kidney failure who are on programmed hemodialysis].
    Konstantinova OV; Ianenko EK; Danilkov AP; Pashkin IN
    Urol Nefrol (Mosk); 1997; (3):23-5. PubMed ID: 9245050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Variations in serum levels of phosphorus (iP), calcium (Ca), calcitonin (iCT) and parathormone (iPTH) in patients under periodic hemodialysis. Effects of exogenous calcitonin therapy].
    Bucciante G; Bernardi A; Biasia F; Milan G; Donato D
    Minerva Med; 1985 Mar; 76(9-10):415-7. PubMed ID: 3982698
    [No Abstract]   [Full Text] [Related]  

  • 20. The molecular conception of rickets pathogenesis. I. Clinical research.
    Nordio S; Antener I; Gatti R; Dentan E
    Med Exp Int J Exp Med; 1968; 18(4):193-222. PubMed ID: 4900159
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.